Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

KALA BIO, Inc. - Common Stock (NQ:KALA)

19.25 +0.63 (+3.38%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 492,752
Open 19.25
Bid (Size) 17.95 (2)
Ask (Size) 19.35 (5)
Prev. Close 18.62
Today's Range 17.03 - 19.69
52wk Range 2.920 - 18.89
Shares Outstanding 6,679,115
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
KALA BIO to Present at H.C. Wainwright 27th Annual Global Investment Conference
From KALA BIO, Inc.
Via GlobeNewswire
KALA BIO Appoints Todd Bazemore as President, Chief Executive Officer and Director
Mr. Bazemore brings over 30 years of extensive leadership experience in the biopharmaceutical industry with a focus on growing rare disease companies 
From KALA BIO, Inc.
Via GlobeNewswire

Performance

YTD
+149.7%
+149.7%
1 Month
+131.4%
+131.4%
3 Month
+343.5%
+343.5%
6 Month
+174.9%
+174.9%
1 Year
+234.2%
+234.2%

More News

Read More
5 Healthcare Stocks On Fire This Week
Via Benzinga
KALA Stock Earnings: Kala Bio Beats EPS for Q2 2024
Via InvestorPlace
Kala Bio (KALA) Q2 Loss Widens 15%
Via The Motley Fool
KALA BIO Reports Second Quarter 2025 Financial Results and Provides Corporate Update
From KALA BIO, Inc.
Via GlobeNewswire
KALA BIO to Present at H.C. Wainwright 5th Annual Ophthalmology Virtual Conference
From KALA BIO, Inc.
Via GlobeNewswire
This Harrow Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
Via Benzinga
KALA BIO Announces Completion of Enrollment in CHASE Clinical Trial Evaluating KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED)
From KALA BIO, Inc.
Via GlobeNewswire
KALA BIO to Host Virtual Key Opinion Leader (KOL) Event to Discuss the Potential of KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED)
From KALA BIO, Inc.
Via GlobeNewswire
KALA BIO to Present at Jefferies Global Healthcare Conference
From KALA BIO, Inc.
Via GlobeNewswire
KALA BIO Reports First Quarter 2025 Financial Results and Provides Corporate Update
From KALA BIO, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
KALA BIO Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
From KALA BIO, Inc.
Via GlobeNewswire
KALA BIO to Present at TD Cowen 45th Annual Health Care Conference
From KALA BIO, Inc.
Via GlobeNewswire
Kala Bio Stock Sinks On CEO Exit, But Retail Feels It’s An Overreaction
Via Stocktwits
Dow Drops More Than 400 Points After CPI Data
Via Talk Markets
Topics Economy Stocks Stocks / Equities
KALA BIO Announces Chief Executive Officer Transition
From KALA BIO, Inc.
Via GlobeNewswire
KALA BIO Announces $10,750,000 Private Placement
From KALA BIO, Inc.
Via GlobeNewswire
KALA BIO to Present at Piper Sandler 36th Annual Healthcare Conference
From KALA BIO, Inc.
Via GlobeNewswire
KALA BIO Reports Third Quarter 2024 Financial Results and Provides Corporate Update
From KALA BIO, Inc.
Via GlobeNewswire
KALA BIO to Present at H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
From KALA BIO, Inc.
Via GlobeNewswire
KALA BIO Reports Second Quarter 2024 Financial Results and Provides Corporate Update
From KALA BIO, Inc.
Via GlobeNewswire
KALA BIO Announces $12,500,000 Private Placement
From KALA BIO, Inc.
Via GlobeNewswire

Frequently Asked Questions

Is KALA BIO, Inc. - Common Stock publicly traded?
Yes, KALA BIO, Inc. - Common Stock is publicly traded.
What exchange does KALA BIO, Inc. - Common Stock trade on?
KALA BIO, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for KALA BIO, Inc. - Common Stock?
The ticker symbol for KALA BIO, Inc. - Common Stock is KALA on the Nasdaq Stock Market
What is the current price of KALA BIO, Inc. - Common Stock?
The current price of KALA BIO, Inc. - Common Stock is 19.25
When was KALA BIO, Inc. - Common Stock last traded?
The last trade of KALA BIO, Inc. - Common Stock was at 09/15/25 04:00 PM ET
What is the market capitalization of KALA BIO, Inc. - Common Stock?
The market capitalization of KALA BIO, Inc. - Common Stock is 128.57M
How many shares of KALA BIO, Inc. - Common Stock are outstanding?
KALA BIO, Inc. - Common Stock has 129M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.